tirzepatide phase 3 study results A 3-year of in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 Updates in Medicine | Phase
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29










![l carnitine supplement uses SENSITIVE]L-Carnitine](https://media.ffycdn.net/eu/metagenics/oTNzHUKWk3qeWoDGnAyk.jpg)
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)












